Skip to main content
abstract news background

Hypertension Symposium: Wednesday, Sept. 20th

Aug 23, 2017

Hypertension Symposium

Wednesday, September 20th, 2017
EIHG Auditorium
15S 2030E
University of Utah, Salt Lake City

RSVP requested


Keynote Speaker: SUSANNE OPARIL, MD – Distinguished Professor of Medicine, University of Alabama at Birmingham

Join us for her keynote presentation: SPRINT Becomes a Marathon: Impact of SPRINT on Hypertension Research & Blood Pressure Management

Dr. Oparil is internationally recognized for her contributions to the fields of hypertension & cardiovascular disease. Throughout her career, she has focused on translating her robust findings from the basic science laboratory into the clinic and into the arena of randomized controlled clinical trials.


8:00-8:30   Breakfast

8:30-8:35   Welcome              
Adam Bress, PharmD, MS – Health System Innovation & Research

8:35-8:45   Cost-Effectiveness of Intensive Systolic Blood Pressure Control
Brandon Bellows, PharmD, MS - Pharmacotherapy

8:45-8:55   Cost-Effectiveness of Intensive Systolic Blood Pressure Treatment in US Patients Aged 75 Years or Older
Natalia Ruiz-Negrón, PharmD - Pharmacotherapy

8:55-9:05   Maternal Health Following Hypertensive Disease of Pregnancy
Lauren Theilen, MD – Obstetrics & Gynaecology                  

9:05-9:15   Effects of Intensive BP Control in CKD
Alfred Cheung, MD – Nephrology & Hypertension           

9:15-9:25   Patient Satisfaction in the SPRINT Study: Data to Date & Future Analysis
Molly Conroy, MD, MPH, FACSM, FAHA – General Internal Medicine          

9:25-9:40   Coffee & Snack Break

9:40-9:50   AOBP:  Implications for SPRINT and Beyond
Barry Stults, MD – General Internal Medicine

9:50-10:00   The Burden of Hypertension in the Developing World
William Weintraub, MD – Cardiology, Christiana Care

10:10-10:20   Intensive SBP Target Mitigates the Age-related Increase in Arterial Stiffness
Mark Supiano, MD - Geriatrics

10:30-10:40   Effects of Intensive Systolic Blood Pressure Control on Kidney and Cardiovascular Outcomes in Those Without Kidney Disease in SPRINT
Srinivasan Beddhu, MD – Nephrology & Hypertension

10:40-10:50   Translating SPRINT into Clinical Practice: The Optimize-SPRINT Project
Andrew Moran, MD, MPH – General Internal Medicine, Columbia University

10:50-11:10   Break

11:10-12:00   SPRINT Becomes a Marathon: Impact of SPRINT on Hypertension Research and Blood Pressure Management
Suzanne Oparil, MD

12:00-1:30   Lunch and “Consult with the Experts” at EIHG Atrium

Presented by

Department of Internal Medicine
Division of General Internal Medicine
Division of Nephrology & Hypertension
Department of Population Health Sciences
Division of Health System Innovation & Research


DISCLOSURE: None of the speakers or planners or anyone in control of content for this continuing medical education activity have any relevant financial relationships since the content does not relate to any healthcare goods or services of an ACCME-defined commercial interest; therefore, there are no relevant financial relationships to disclose.

AMA Credit: The University of Utah School of Medicine designates this Live activity for a maximum of 5.00 AMA PRA Category 1 Credit(s)™.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ACCREDITATION:  The University of Utah School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

NONDISCRIMINATION AND DISABILITY ACCOMMODATION STATEMENT: The University of Utah does not exclude, deny benefits to or otherwise discriminate against any person on the basis of race, color, national origin, sex, disability, age, veteran’s status, religion, gender identity/expression, genetic information, or sexual orientation in admission to or participation in its programs and activities.  Reasonable accommodations will be provided to qualified individuals with disabilities upon request, with reasonable notice.  Requests for accommodations or inquiries or complaints about University nondiscrimination and disability/access policies may be directed to the Director, OEO/AA, Title IX/Section 504/ADA Coordinator, 201 S President’s Circle, RM 135, Salt Lake City, UT 84112, 801-581-8365 (Voice/TTY), 801-585-5746 (Fax).